Hospital Universitario 12 de Octubre

Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review (2026) Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, et al. Journal article Recessive loss of DIAPH1 function causes a progressive neurodevelopmental syndrome with variable immunological involvement (2026) Galassi Deforie V, Maroofian R, Karagoz I, Godwin A, Al Sheikh E, Gestri G, Zaki MS, et al. Journal article Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database (2026) Käs F, Elhai M, Becker MO, Dobrota R, Mihai C, Sauer G, Tofani L, et al. Journal article Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reports (2026) Mahfoud F, Kandzari DE, Schlaich MP, Schmieder R, Lauder L, Ruilope L, Narkiewicz K, et al. Journal article Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease (2025) Schlaich MP, Mahfoud F, Böhm M, Narkiewicz K, Ruilope L, Williams B, Mancia G, et al. Journal article Sex stratified analysis of patients with resistant hypertension from the Global SYMPLICITY Registry of renal denervation (2025) Mihailidou AS, Mahfoud F, Schlaich M, Schmieder R, Narkiewicz K, Ruilope L, Fahy M, et al. Journal article A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. (2025) Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, et al. Journal article Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension Study (2025) Biedermann L, Schlag C, Straumann A, Lucendo AJ, Miehlke S, Vieth M, Santander C, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article